{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-015082","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2022-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.827654+00:00","generated_at":"2026-06-23T02:35:10.858062+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CytoDyn director Scott Kelly resigns; Stephen Simes appointed to board.","bullets":["Scott Kelly resigned as director effective Oct 13, 2022; remains CMO and Head of Business Development.","Stephen Simes appointed director same day, filling Kelly's vacancy.","Simes has 40+ years pharma experience, former CEO of BioSante and RestorGenex, director at several firms.","Simes compensated per nonemployee director policies with cash retainers and stock options.","No disclosable transactions or family relationships between Simes and other officers/directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-015082","json":"https://secwatch.observer/filing/0001558370-22-015082.json","markdown":"https://secwatch.observer/filing/0001558370-22-015082.md","text":"https://secwatch.observer/filing/0001558370-22-015082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022015082/0001558370-22-015082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022015082/cydy-20221013x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:35:10.858062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"36f52d1f54","claim":"Stephen M. Simes was appointed as Director at CytoDyn Inc..","evidence_excerpt":"On October 13, 2022, the Company’s Board of Directors (the “Board”) approved the appointment of Stephen M. Simes (“Mr. Simes”) as a director of the Company, effective October 13, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022015082/0001558370-22-015082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cbf9c12d8e","claim":"Scott A. Kelly resigned as Director at CytoDyn Inc..","evidence_excerpt":"On October 13, 2022, Scott A. Kelly, M.D. (“Dr. Kelly”) provided written notice to the Board Chair of CytoDyn Inc. (the “Company”) of his resignation as a director of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022015082/0001558370-22-015082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}